{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T20:38:40Z","timestamp":1779223120621,"version":"3.51.4"},"reference-count":46,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Int"],"DOI":"10.3892\/mi.2022.51","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T11:48:16Z","timestamp":1659440896000},"source":"Crossref","is-referenced-by-count":5,"title":["Role of histone deacetylase inhibitors in diabetic cardiomyopathy in experimental models (Review)"],"prefix":"10.3892","volume":"2","author":[{"given":"Anna","family":"Garmpi","sequence":"first","affiliation":[{"name":"First Department of Propedeutic Internal Medicine, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527\u00a0Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Damaskos","sequence":"additional","affiliation":[{"name":"Renal Transplantation Unit, Laiko General Hospital, 11527\u00a0Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Garmpis","sequence":"additional","affiliation":[{"name":"N.S. Christeas Laboratory of Experimental Surgery and Surgical Research, Medical School, National and Kapodistrian University of Athens, 11527\u00a0Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaios-Vasileios","family":"Kaminiotis","sequence":"additional","affiliation":[{"name":"Cardiothoracic Department, Derriford Hospital, University Hospitals Plymouth, PL6 8DH Plymouth, United Kingdom,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki","family":"Georgakopoulou","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases\u2011COVID\u201119 Unit, Laiko General Hospital, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demetrios","family":"Spandidos","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petros","family":"Papalexis","sequence":"additional","affiliation":[{"name":"Unit of Endocrinology, First Department of Internal Medicine, Laiko General Hospital, National and Kapodistrian University of Athens, 11527\u00a0Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos","family":"Diamantis","sequence":"additional","affiliation":[{"name":"Endocrinology Unit, Academic Department of Internal Medicine, Agioi Anargyroi General Oncology Hospital, National and Kapodistrian University of Athens, 14564 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandros","family":"Patsouras","sequence":"additional","affiliation":[{"name":"Second Department of Pulmonology, Sotiria Hospital, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Kyriakos","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Nutrition, General Hospital Santa Lucia, 30202 Cartagena, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyriakos","family":"Tarantinos","sequence":"additional","affiliation":[{"name":"1st Pulmonology Department Sismanogleio Hospital, 15126 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Syllaios","sequence":"additional","affiliation":[{"name":"First Department of Surgery, Laiko General Hospital, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Marinos","sequence":"additional","affiliation":[{"name":"Department of Hygiene, Epidemiology and Medical Statistics, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Kouraklis","sequence":"additional","affiliation":[{"name":"Department of Surgery, Evgenideio Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Dimitroulis","sequence":"additional","affiliation":[{"name":"Second Department of Propedeutic Surgery, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527\u00a0Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2022,8,2]]},"reference":[{"key":"key20220922141234_b1-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.jcmg.2018.03.015","article-title":"Diagnosis of nonischemic stage B heart failure in type 2 diabetes mellitus","volume":"11","author":"Wang","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2136","key":"key20220922141234_b2-MI-2-4-00051","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17122136","article-title":"Diabetic cardiomyopathy: Does the type of diabetes matter?","volume":"17","author":"H\u00f6lscher","year":"2016","journal-title":"Int J Mol Sci"},{"key":"key20220922141234_b3-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"266","DOI":"10.4070\/kcj.2015.45.4.266","article-title":"Diabetic cardiomyopathy; Summary of 41 years","volume":"45","author":"Yilmaz","year":"2015","journal-title":"Korean Circ J"},{"key":"key20220922141234_b4-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"13A","DOI":"10.1016\/j.amjcard.2003.11.003","article-title":"Diabetic cardiomyopathy: A metabolic perspective","volume":"93","author":"Avogaro","year":"2004","journal-title":"Am J Cardiol"},{"key":"key20220922141234_b5-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: An update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ Res"},{"key":"key20220922141234_b6-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.cell.2010.02.043","article-title":"Anti-inflammatory agents: Present and future","volume":"140","author":"Dinarello","year":"2010","journal-title":"Cell"},{"key":"key20220922141234_b7-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1002\/jcb.25902","article-title":"Sodium butyrate protects-against high fat diet-induced cardiac dysfunction and metabolic disorders in type II diabetic mice","volume":"118","author":"Zhang","year":"2017","journal-title":"J Cell Biochem"},{"key":"key20220922141234_b8-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","article-title":"Diabetic cardiomyopathy: A hyperglycaemia- and insulin-resistance-induced heart disease","volume":"61","author":"Jia","year":"2018","journal-title":"Diabetologia"},{"key":"key20220922141234_b9-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.hfc.2011.08.008","article-title":"Diabetes and the risk of heart failure","volume":"8","author":"Dhingra","year":"2012","journal-title":"Heart Fail Clin"},{"key":"key20220922141234_b10-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"52","DOI":"10.15420\/cfr.2016:20:2","article-title":"Heart failure in patients with diabetes mellitus","volume":"3","author":"Rosano","year":"2017","journal-title":"Card Fail Rev"},{"key":"key20220922141234_b11-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jacc.2017.11.019","article-title":"Implications of underlying mechanisms for the recognition and management of diabetic cardiomyopathy","volume":"71","author":"Marwick","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"key20220922141234_b12-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4239\/wjd.v9.i1.1","article-title":"Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment","volume":"9","author":"Serhiyenko","year":"2018","journal-title":"World J Diabetes"},{"key":"key20220922141234_b13-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1093\/eurheartj\/ehv442","article-title":"Cardiac energetics, oxygenation, and perfusion during increased workload in patients with type 2 diabetes mellitus","volume":"37","author":"Levelt","year":"2016","journal-title":"Eur Heart J"},{"key":"key20220922141234_b14-MI-2-4-00051","first-page":"846","article-title":"Histone deacetylase inhibitors as a new anticancer option: How far can we go with expectations?","volume":"23","author":"Garmpi","year":"2018","journal-title":"J BUON"},{"issue":"a018713","key":"key20220922141234_b15-MI-2-4-00051","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a018713","article-title":"Erasers of histone acetylation: The histone deacetylase enzymes","volume":"6","author":"Seto","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"key20220922141234_b16-MI-2-4-00051","article-title":"Histone deacetylase inhibitors: Updated studies in various epigenetic-related diseases","volume":"2","author":"Zwergel","year":"2016","journal-title":"J Clin Epigenet"},{"key":"key20220922141234_b17-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.2174\/0929867328666210915105929","article-title":"Histone deacetylases and their inhibitors in colorectal cancer therapy: Current evidence and future considerations","volume":"29","author":"Garmpis","year":"2022","journal-title":"Curr Med Chem"},{"issue":"223","key":"key20220922141234_b18-MI-2-4-00051","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11030223","article-title":"Histone deacetylase inhibitors in the treatment of hepatocellular carcinoma: Current evidence and future opportunities","volume":"11","author":"Garmpis","year":"2021","journal-title":"J Pers Med"},{"key":"key20220922141234_b19-MI-2-4-00051","first-page":"3129","article-title":"Histone deacetylase (HDAC) inhibitors: Current evidence for therapeutic activities in pancreatic cancer","volume":"35","author":"Damaskos","year":"2015","journal-title":"Anticancer Res"},{"key":"key20220922141234_b20-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"35","DOI":"10.21873\/anticanres.11286","article-title":"Histone deacetylase inhibitors: An attractive therapeutic strategy against breast cancer","volume":"37","author":"Damaskos","year":"2017","journal-title":"Anticancer Res"},{"key":"key20220922141234_b21-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"299","DOI":"10.21873\/cgp.20041","article-title":"Histone deacetylases as new therapeutic targets in triple-negative breast cancer: Progress and promises","volume":"14","author":"Garmpis","year":"2017","journal-title":"Cancer Genomics Proteomics"},{"key":"key20220922141234_b22-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.21873\/anticanres.11070","article-title":"Histone deacetylase inhibitors: A novel therapeutic weapon against medullary thyroid cancer?","volume":"36","author":"Damaskos","year":"2016","journal-title":"Anticancer Res"},{"key":"key20220922141234_b23-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.21873\/anticanres.13220","article-title":"Histone deacetylase inhibitors and anaplastic thyroid carcinoma","volume":"39","author":"Spartalis","year":"2019","journal-title":"Anticancer Res"},{"key":"key20220922141234_b24-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"37","DOI":"10.21873\/anticanres.12189","article-title":"Histone deacetylase inhibitors as a novel targeted therapy against non-small cell lung cancer: Where are we now and what should we expect?","volume":"38","author":"Damaskos","year":"2018","journal-title":"Anticancer Res"},{"key":"key20220922141234_b25-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"950","DOI":"10.26355\/eurrev_201802_14376","article-title":"Targeting histone deacetylases in endometrial cancer: A paradigm-shifting therapeutic strategy?","volume":"22","author":"Garmpis","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key20220922141234_b26-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.21873\/anticanres.12665","article-title":"The role of histone deacetylase inhibitors in uveal melanoma: Current evidence","volume":"38","author":"Moschos","year":"2018","journal-title":"Anticancer Res"},{"key":"key20220922141234_b27-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"5355","DOI":"10.21873\/anticanres.11961","article-title":"Targeting histone deacetylases in malignant melanoma: A future therapeutic agent or just great expectations?","volume":"37","author":"Garmpis","year":"2017","journal-title":"Anticancer Res"},{"key":"key20220922141234_b28-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2217\/epi.11.67","article-title":"Epigenetic treatment of neurological disease","volume":"3","author":"Gray","year":"2011","journal-title":"Epigenomics"},{"issue":"729","key":"key20220922141234_b29-MI-2-4-00051","doi-asserted-by":"publisher","DOI":"10.3390\/nu8110729","article-title":"Parenchymal and stromal cells contribute to pro-inflammatory myocardial environment at early stages of diabetes: Protective role of resveratrol","volume":"8","author":"Savi","year":"2016","journal-title":"Nutrients"},{"key":"key20220922141234_b30-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","article-title":"Molecular mechanisms of diabetic cardiomyopathy","volume":"57","author":"Bugger","year":"2014","journal-title":"Diabetologia"},{"issue":"99","key":"key20220922141234_b31-MI-2-4-00051","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-015-0262-8","article-title":"Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice","volume":"14","author":"Chen","year":"2015","journal-title":"Cardiovasc Diabetol"},{"issue":"5938740","key":"key20220922141234_b32-MI-2-4-00051","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5938740","article-title":"HDAC inhibition modulates cardiac PPARs and fatty acid metabolism in diabetic cardiomyopathy","volume":"2016","author":"Lee","year":"2016","journal-title":"PPAR Res"},{"key":"key20220922141234_b33-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3892\/mmr.2017.7905","article-title":"Histone deacetylase inhibition of cardiac autophagy in rats on a high-fat diet with low-dose streptozotocin-induced type 2 diabetes mellitus","volume":"17","author":"Lee","year":"2018","journal-title":"Mol Med Rep"},{"issue":"8208065","key":"key20220922141234_b34-MI-2-4-00051","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8208065","article-title":"Suppression of excessive histone deacetylases activity in diabetic hearts attenuates myocardial ischemia\/reperfusion injury via mitochondria apoptosis pathway","volume":"2017","author":"Wu","year":"2017","journal-title":"J Diabetes Res"},{"key":"key20220922141234_b35-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1161\/CIRCRESAHA.108.175018","article-title":"Phosphatidylinositol 3-kinase gamma is a critical mediator of myocardial ischemic and adenosine-mediated preconditioning","volume":"103","author":"Ban","year":"2008","journal-title":"Circ Res"},{"issue":"9494052","key":"key20220922141234_b36-MI-2-4-00051","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9494052","article-title":"Inhibition of HDAC6 activity alleviates myocardial ischemia\/reperfusion injury in diabetic rats: Potential role of peroxiredoxin 1 acetylation and redox regulation","volume":"2018","author":"Leng","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"key20220922141234_b37-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1042\/CS20170064","article-title":"Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1\/2 pathway","volume":"131","author":"Xu","year":"2017","journal-title":"Clin Sci (Lond)"},{"key":"key20220922141234_b38-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.3390\/ijms20081873","article-title":"The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) restores cardiomyocyte contractility in a rat model of early diabetes","volume":"20","author":"Bocchi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"key20220922141234_b39-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.yjmcc.2019.04.003","article-title":"Histone deacetylases in cardiovascular and metabolic diseases","volume":"130","author":"Bagshi","year":"2019","journal-title":"J Mol Cell Cardiol"},{"key":"key20220922141234_b40-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00125-006-0562-3","article-title":"Inhibition of histone deacetylases prevents cytokine-induced toxicity in beta cells","volume":"50","author":"Larsen","year":"2007","journal-title":"Diabetologia"},{"key":"key20220922141234_b41-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1164\/rccm.201007-1106OC","article-title":"Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats","volume":"183","author":"Bogaard","year":"2011","journal-title":"Am J Respir Crit Cure Med"},{"key":"key20220922141234_b42-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1111\/j.1463-1326.2010.01278.x","article-title":"Role of autophagy in \u03b2-cell function and mass","volume":"2 (12 Suppl)","author":"Hur","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"key20220922141234_b43-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1074\/jbc.M110.157107","article-title":"Class II histone deacetylases limit GLUT4 gene expression during adipocyte differentiation","volume":"286","author":"Weems","year":"2011","journal-title":"J Biol Chem"},{"key":"key20220922141234_b44-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"14285","DOI":"10.1074\/jbc.273.23.14285","article-title":"Myocyte enhancer factor 2 (MEF2)-binding site is required for GLUT4 gene expression in transgenic mice. Regulation of MEF2 DNA binding activity in insulin-deficient diabetes","volume":"273","author":"Thai","year":"1998","journal-title":"J Biol Chem"},{"key":"key20220922141234_b45-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/cphy.c150016","article-title":"Glucose transporters in cardiac metabolism and hypertrophy","volume":"6","author":"Shao","year":"2015","journal-title":"Compr Physiol"},{"key":"key20220922141234_b46-MI-2-4-00051","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1016\/j.ijcard.2013.07.111","article-title":"Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure","volume":"168","author":"Kao","year":"2013","journal-title":"Int J Cardiol"}],"container-title":["Medicine International"],"original-title":[],"deposited":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T11:12:50Z","timestamp":1663845170000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mi.2022.51"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,2]]},"references-count":46,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,8,2]]}},"URL":"https:\/\/doi.org\/10.3892\/mi.2022.51","relation":{},"ISSN":["2754-3242","2754-1304"],"issn-type":[{"value":"2754-3242","type":"print"},{"value":"2754-1304","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,2]]},"article-number":"26"}}